95 related articles for article (PubMed ID: 16886093)
1. Redistribution of Foscan from plasma proteins to model membranes.
Sasnouski S; Kachatkou D; Zorin V; Guillemin F; Bezdetnaya L
Photochem Photobiol Sci; 2006 Aug; 5(8):770-7. PubMed ID: 16886093
[TBL] [Abstract][Full Text] [Related]
2. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
Maugain E; Sasnouski S; Zorin V; Merlin JL; Guillemin F; Bezdetnaya L
Oncol Rep; 2004 Sep; 12(3):639-45. PubMed ID: 15289849
[TBL] [Abstract][Full Text] [Related]
3. Investigation of Foscan interactions with plasma proteins.
Sasnouski S; Zorin V; Khludeyev I; D'Hallewin MA; Guillemin F; Bezdetnaya L
Biochim Biophys Acta; 2005 Oct; 1725(3):394-402. PubMed ID: 16051442
[TBL] [Abstract][Full Text] [Related]
4. Redistribution of meta-tetra(hydroxyphenyl)chlorin (m-THPC) from conventional and PEGylated liposomes to biological substrates.
Reshetov V; Kachatkou D; Shmigol T; Zorin V; D'Hallewin MA; Guillemin F; Bezdetnaya L
Photochem Photobiol Sci; 2011 Jun; 10(6):911-9. PubMed ID: 21311777
[TBL] [Abstract][Full Text] [Related]
5. Dithiaporphyrin derivatives as photosensitizers in membranes and cells.
Minnes R; Weitman H; You Y; Detty MR; Ehrenberg B
J Phys Chem B; 2008 Mar; 112(10):3268-76. PubMed ID: 18278897
[TBL] [Abstract][Full Text] [Related]
6. Comparative characterization of the cellular uptake and photodynamic efficiency of Foscan® and Fospeg in a human prostate cancer cell line.
Petri A; Yova D; Alexandratou E; Kyriazi M; Rallis M
Photodiagnosis Photodyn Ther; 2012 Dec; 9(4):344-54. PubMed ID: 23200016
[TBL] [Abstract][Full Text] [Related]
7. Photophysical studies and in vitro skin permeation/retention of Foscan/nanoemulsion (NE) applicable to photodynamic therapy skin cancer treatment.
Primo FL; Bentley MV; Tedesco AC
J Nanosci Nanotechnol; 2008 Jan; 8(1):340-7. PubMed ID: 18468080
[TBL] [Abstract][Full Text] [Related]
8. Reaction of the m-THPC triplet state with the antioxidant Trolox and the anesthetic Propofol: modulation of photosensitization mechanisms relevant to photodynamic therapy?
Friaa O; Maillard P; Brault D
Photochem Photobiol Sci; 2012 Apr; 11(4):703-14. PubMed ID: 22307091
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence resonance energy transfer reveals a binding site of a photosensitizer for photodynamic therapy.
Morris RL; Azizuddin K; Lam M; Berlin J; Nieminen AL; Kenney ME; Samia AC; Burda C; Oleinick NL
Cancer Res; 2003 Sep; 63(17):5194-7. PubMed ID: 14500343
[TBL] [Abstract][Full Text] [Related]
10. The cellular uptake of meta-tetra(hydroxyphenyl)chlorin entrapped in organically modified silica nanoparticles is mediated by serum proteins.
Compagnin C; Baù L; Mognato M; Celotti L; Miotto G; Arduini M; Moret F; Fede C; Selvestrel F; Rio Echevarria IM; Mancin F; Reddi E
Nanotechnology; 2009 Aug; 20(34):345101. PubMed ID: 19652275
[TBL] [Abstract][Full Text] [Related]
11. Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines.
Kiesslich T; Berlanda J; Plaetzer K; Krammer B; Berr F
Photochem Photobiol Sci; 2007 Jun; 6(6):619-27. PubMed ID: 17549263
[TBL] [Abstract][Full Text] [Related]
12. Relationship between subcellular localisation of Foscan and caspase activation in photosensitised MCF-7 cells.
Marchal S; François A; Dumas D; Guillemin F; Bezdetnaya L
Br J Cancer; 2007 Mar; 96(6):944-51. PubMed ID: 17325708
[TBL] [Abstract][Full Text] [Related]
13. Interaction of liposomal formulations of meta-tetra(hydroxyphenyl)chlorin (temoporfin) with serum proteins: protein binding and liposome destruction.
Reshetov V; Zorin V; Siupa A; D'Hallewin MA; Guillemin F; Bezdetnaya L
Photochem Photobiol; 2012; 88(5):1256-64. PubMed ID: 22607362
[TBL] [Abstract][Full Text] [Related]
14. Photophysical origin of the reduced photodynamic therapy activity of temocene compared to Foscan®: insights from theory.
Alberto ME; Marino T; Quartarolo AD; Russo N
Phys Chem Chem Phys; 2013 Oct; 15(38):16167-71. PubMed ID: 23985895
[TBL] [Abstract][Full Text] [Related]
15. Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas.
Betz CS; Rauschning W; Stranadko EP; Riabov MV; Albrecht V; Nifantiev NE; Hopper C
Lasers Surg Med; 2008 Jul; 40(5):300-11. PubMed ID: 18563776
[TBL] [Abstract][Full Text] [Related]
16. Kinetics and thermodynamics of lipid amphiphile exchange between lipoproteins and albumin in serum.
Estronca LM; Moreno MJ; Laranjinha JA; Almeida LM; Vaz WL
Biophys J; 2005 Jan; 88(1):557-65. PubMed ID: 15465860
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy with intratumoral administration of Lipid-Based mTHPC in a model of breast cancer recurrence.
D'Hallewin MA; Kochetkov D; Viry-Babel Y; Leroux A; Werkmeister E; Dumas D; Gräfe S; Zorin V; Guillemin F; Bezdetnaya L
Lasers Surg Med; 2008 Oct; 40(8):543-9. PubMed ID: 18798287
[TBL] [Abstract][Full Text] [Related]
18. Pdots, a new type of nanoparticle, bind to mTHPC via their lipid modified surface and exhibit very high FRET efficiency between the core and the sensitizer.
Haupt S; Lazar I; Weitman H; Senge MO; Ehrenberg B
Phys Chem Chem Phys; 2015 May; 17(17):11412-22. PubMed ID: 25853434
[TBL] [Abstract][Full Text] [Related]
19. Identification and partial characterization of an unusual distribution of the photosensitizer meta-tetrahydroxyphenyl chlorin (temoporfin) in human plasma.
Hopkinson HJ; Vernon DI; Brown SB
Photochem Photobiol; 1999 Apr; 69(4):482-8. PubMed ID: 10212581
[TBL] [Abstract][Full Text] [Related]
20. Steady state and time-resolved fluorescence investigation of the specific binding of two chlorin derivatives with human serum albumin.
Patel S; Datta A
J Phys Chem B; 2007 Sep; 111(35):10557-62. PubMed ID: 17705527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
